103 results on '"Lanotte M"'
Search Results
2. Comparison of uniaxial tension-compression fatigue test results with SCB test performance indicators developed for performance-based mix design procedure
3. Prediction of HMA fatigue performances using different Visco-Elastic Continuum Damage (VECD) models
4. Determination of AASHTO 1993 layer coefficients considering time- and temperature-dependency of the asphalt mixture
5. Influence of lateral confining pressure on flow number tests
6. The neurology-stability-epidural compression assessment: a new score to establish the need for surgery in spinal metastases
7. Evaluation of rutting resistance of rubberized gap-graded asphalt mixtures
8. Corrigendum to: “The Neurology-Stability-Epidural compression assessment: A new score to establish the need for surgery in spinal metastases” Clin. Neurol. Neurosurg. 195 (2020 Aug) 105896
9. Pituitary surgery during Covid-19: a first hand experience and evaluation
10. WITHDRAWN: Procalcitonin and mid regional-pro-adrenomedullin promising markers for sepsis diagnosis and prognosis
11. Gait analysis pre/post tap-test to prognosticate shunt responsiveness in normal pressure hydrocephalus
12. Characterization of crumb rubber from end-of-life tyres for paving applications
13. Experimental glioblastoma in the fisher rat model: Treatment with a biocompatible system as carrier of methotrexate
14. Are acute subdural hematomas possible without head trauma?
15. LIST OF CONTRIBUTORS
16. Hematoporphyrin and Laser for the Treatment of CNS Infections
17. Preliminary Experiences with Argon and Nd: YAG Scalpel Laser in Neurosurgery
18. INTERMEDIATES OF DNA SYNTHESIS OF MOUSE THYMOCYTES
19. Stimulation of the subthalamic area modulating movement and behavior
20. P08.10 * SINGLE BRAIN METASTASIS 9 YEARS AFTER ORTHOTOPIC LIVER TRANSPLANT WITH HISTOLOGICAL NEGATIVE EXPIANTED LIVER: CASE REPORT
21. P17.26 * IS NICU MANDATORY AFTER SURGERY IN ADULT HGG? A SINGLE CENTER EXPERIENCE
22. P17.27 * HIGH GRADE GLIOMAS IN ELDERLY PATIENTS: RESULTS OF SURGERY AND INFLUENCE ON KARNOFSKY'S PERFORMANCE STATUS
23. P08.11 * SURGICAL MANAGEMENT OF BRAIN METASTASES FROM LUNG ADENOCARCINOMA: A SINGLE CENTER EXPERIENCE AND REFLECTIONS ON MULTIPLE LESIONS
24. P12.04 * GLIOMATOSIS CEREBRI: IS THERE A ROLE FOR SURGERY OTHER THAN BIOPSY?
25. Solid Lipid Nanoparticles as Antineoplastic Drug Vehicles in Glioblastoma Multiforme: In-vitro and In-vivo Pathological Effects
26. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?
27. Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis
28. Is there a dominant subthalamic nucleus? Evidence from the effect of deep brain stimulation on gait performance in subjects with Parkinson's disease
29. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients
30. Probable REM sleep behaviour disorder and STN-DBS outcome in Parkinson's Disease
31. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells
32. Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease
33. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease
34. Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis
35. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease
36. Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP
37. A PARP-1/JNK1 cascade participates in the synergistic apoptotic effect of TNFα and all-trans retinoic acid in APL cells
38. When words are painful: Unraveling the mechanisms of the nocebo effect
39. Apathy and verbal fluency in STN-stimulated PD patients
40. Motor and Nonmotor Symptom Follow-Up in Parkinsonian Patients after Deep Brain Stimulation of the Subthalamic Nucleus
41. Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson’s disease
42. Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?
43. Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL
44. Chronic Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson’s Disease: Effects on Cognition, Mood, Anxiety and Personality Traits
45. Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death
46. Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson?s disease
47. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation
48. Quantitative analysis of gait in Parkinson's disease: a pilot study on the effects of bilateral sub-thalamic stimulation
49. High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis
50. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.